Anthropic announced plans to develop drugs directly, signaling a shift in how AI companies may compete with the pharmaceutical industry.
Here's why third-party AI risk is the governance conversation businesses can't afford to skip.
Everyone is talking about Human in the Loop AI governance. But if your strategy is just 'someone clicked Approve', you've built a liability chain.
Technology decisions made without analysis cost organizations time, money, and momentum. Here's why the first conversation should never be about the...
The U.S. government shut down Anthropic's Mythos 5 and Fable 5 AI models overnight. But if you think that made AI threats disappear, think again.
Agentic AI goes far beyond chatbots. Here's what it actually means, how it works, and why businesses need to understand it now.
AI bias and AI model drift are silent risks hiding inside the tools your business depends on. Here's what they are and how to stay ahead of them.
AI doesn't fit the traditional QA mold. Here's why regulated industries must shift from gatekeeping to collaborative quality and AI operational...
Every AI agent needs guard rails from day one—not just at the platform level. Learn how to build scalable AI governance into your agents before...
Amazon Bio Discovery, an AI-driven platform unifying drug discovery workflows. Learn how it's compressing timelines and reshaping life sciences...